RED HOT Contributors


Drugmaker Endo's third-quarter earnings forecast tops estimates


(Reuters) – Drugmaker Endo International Plc on Monday forecast earnings for the third quarter above analysts’ estimates.

The company expects adjusted earnings from continuing operations of about 85 cents per share for the quarter ended Sept. 30. Analysts on average were expecting 66 cents, according to Thomson Reuters I/B/E/S.

Endo’s shares jumped 16.5 percent to $6.85 in trading before the bell.

Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar

Our Standards:The Thomson Reuters Trust Principles.


We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast